Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research
収録刊行物
-
- Vaccine
-
Vaccine 25 (21), 4203-4212, 2007-05
Elsevier BV